36 related articles for article (PubMed ID: 36122786)
1. DSC, FTIR and Raman Spectroscopy Coupled with Multivariate Analysis in a Study of Co-Crystals of Pharmaceutical Interest.
Garbacz P; Wesolowski M
Molecules; 2018 Aug; 23(9):. PubMed ID: 30149571
[TBL] [Abstract][Full Text] [Related]
2. Binary Mixtures of Meloxicam and L-Tartaric Acid for Oral Bioavailability Modulation of Pharmaceutical Dosage Forms.
Macasoi C; Meltzer V; Stanculescu I; Romanitan C; Pincu E
J Funct Biomater; 2024 Apr; 15(4):. PubMed ID: 38667561
[TBL] [Abstract][Full Text] [Related]
3. The Study of Amorphous Kaempferol Dispersions Involving FT-IR Spectroscopy.
Rosiak N; Tykarska E; Cielecka-Piontek J
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138984
[TBL] [Abstract][Full Text] [Related]
4. Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third Component.
Ueda H; Hirakawa Y; Miyano T; Nakayama Y; Hatanaka Y; Uchiyama H; Tozuka Y; Kadota K
Mol Pharm; 2023 Dec; 20(12):6368-6379. PubMed ID: 37942959
[TBL] [Abstract][Full Text] [Related]
5. Structure and Glass Transition Temperature of Amorphous Dispersions of Model Pharmaceuticals with Nucleobases from Molecular Dynamics.
Červinka C; Fulem M
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452214
[TBL] [Abstract][Full Text] [Related]
6. Current and potential applications of simultaneous DSC-FTIR microspectroscopy for pharmaceutical analysis.
Lin SY
J Food Drug Anal; 2021 Jun; 29(2):182-202. PubMed ID: 35696204
[TBL] [Abstract][Full Text] [Related]
7. Impact of drug loading in mesoporous silica-amorphous formulations on the physical stability of drugs with high recrystallization tendency.
Antonino RSCMQ; Ruggiero M; Song Z; Nascimento TL; Lima EM; Bohr A; Knopp MM; Löbmann K
Int J Pharm X; 2019 Dec; 1():100026. PubMed ID: 31517291
[TBL] [Abstract][Full Text] [Related]
8. Genistein Co-Amorphous Systems with Amino Acids: An Investigation into Enhanced Solubility and Biological Activity.
Garbiec E; Rosiak N; Zalewski P; Tajber L; Cielecka-Piontek J
Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38139995
[TBL] [Abstract][Full Text] [Related]
9. Amorphous Solid Forms of Ranolazine and Tryptophan and Their Relaxation to Metastable Polymorphs.
Silva JFC; Pereira Silva PS; Ramos Silva M; Fantechi E; Chelazzi L; Ciattini S; Eusébio MES; Rosado MTS
Cryst Growth Des; 2023 Sep; 23(9):6679-6691. PubMed ID: 37692331
[TBL] [Abstract][Full Text] [Related]
10. New crystal forms and amorphous phase of sophoricoside: X-ray structures and characterization.
Xing C; Zhang GS; Gong NB; Hua Du G; Lu Y
R Soc Open Sci; 2019 Jan; 6(1):181905. PubMed ID: 30800407
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopic and Computational Study of ZnCl
Kalhor P; Sun Z; Yu Z
J Phys Chem B; 2024 Mar; 128(10):2490-2503. PubMed ID: 38424008
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions of hydrated co-amorphous systems of prilocaine and lidocaine.
Xu X; Rades T; Grohganz H
Int J Pharm; 2024 Feb; 651():123807. PubMed ID: 38220121
[TBL] [Abstract][Full Text] [Related]
13. Analysis of unknown (unlabeled/mislabeled) drug products for active pharmaceutical ingredients and related substances by an international mail facility satellite laboratory equipped with rapid screening devices.
Lanzarotta A; Kern S; Batson J; Collins M; Patel A; Altaf M; Arrecis J; Boyd B; Gonzalez Illan F; Griffin KM; Howe G; Hudson-Davis M; Kimani M; LaGarde D; Laguerre D; Loh M; Lorenz L; Morales-Garcia F; Sterling ME; Reimer AM; Thatcher M; Wetherby AE
J Forensic Sci; 2024 Jul; 69(4):1212-1221. PubMed ID: 38751027
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic Analysis of n-Nonadecane (C
Guo W; Xing Y; Wen W; Su W; Hou C; Li G; Ye L
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930788
[TBL] [Abstract][Full Text] [Related]
15. Detecting different amorphous - Amorphous phase separation patterns in co-amorphous mixtures with high resolution imaging FTIR spectroscopy.
Kilpeläinen T; Ervasti T; Uurasjärvi E; Koistinen A; Ketolainen J; Korhonen O; Pajula K
Eur J Pharm Biopharm; 2022 Nov; 180():161-169. PubMed ID: 36122786
[TBL] [Abstract][Full Text] [Related]
16. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems.
Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O
Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
18. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection.
Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610
[TBL] [Abstract][Full Text] [Related]
19. What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
Newman A; Zografi G
Mol Pharm; 2022 Feb; 19(2):378-391. PubMed ID: 34378939
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]